At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
HIFUdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Presurgical Evaluation of Nonmelanoma Skin Cancers Using High Frequency Ultrasound
In Brief
A clinical study evaluating HIFU for Skin Cancer, Non-Melanoma. Completed, enrolled 40 participants across 1 site.
Detailed Summary
1. To ensure complete elimination of lesions with maximum preservation of function and aesthetics. 2. To elaborate the Ultrasonographic features of skin cancers. 3. To determine the accuracy of HIFU to assess the margins of skin lesions and its safety margins by histopathiological examination.. 4. To follow up the patient postoperatively for incomplete excision or recurrence by clinical and HIFU examination.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Cancer, Non-Melanoma
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMar 2018
Enrollment StartApr 2018
Primary CompletionMay 2022
Study CompletionJun 2022
TodayJul 2026
First PostedMar 8, 2018
Enrollment StartApr 1, 2018
Primary CompletionMay 15, 2022
Study CompletionJun 13, 2022
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 8.3 years ago
Interventions
HIFUdevice
Ultrasound (Esaota MyLabSeven) imaging system using (SL2325) probe with (6-19 MHz) frequency